-
Study aim
-
Effect of prescription of drugs on acute complications of Transurethral Lithotripsy
-
Design
-
In this parallel clinical trial, block randomization is performed using an online program. In phase 3, 3 medications and a placebo are used to assess the efficacy of different medications in decreasing transurethral lithotripsy complications in 400 patients.
-
Settings and conduct
-
In this study, at Sina Hospital in Tehran, patients who are candidates for transurethral lithotripsy are randomly and blindly divided into four groups, and with three drugs in three groups and in group four without drugs, the prevalence of intervention complications is assessed.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria:
TUL candidate patients
Exclusion criteria:
Previous ureteral manipulation
Having a DJ (Double J) or ureteral catheter
Creatinine above 1.5 mg / dL
Age over 65 years
Weight less than 50 kg
Contraindications or allergies to prescribed drugs
Patients who are taking one of the above three drugs for any reason before seeking TUL.
Patient dissatisfaction with participating in the research project
-
Intervention groups
-
Four drug groups (tamsulosin, serum normal saline, ketorolac, and hyoscine)
The first group received only one liter of normal saline (placebo) before TUL.
The second group received tamsulosin capsules two nights before surgery.
The third group received ketorolac before TUL with one liter of normal saline at least one hour before surgery.
The fourth group received an ampoule of hyoscine with one liter of normal saline at least one hour before TUL.
-
Main outcome variables
-
Bladder injury, Ureterovesical junction injury, ureteral mucosa elevation, ureteral perforation, inability to reach the ureteral stone, inability to enter the ureter, ureteral avulsion, and need for a narrower ureteroscope